DexCom Valuation
| D1EX34 Stock | BRL 9.59 0.05 0.52% |
At this time, the firm appears to be undervalued. DexCom Inc shows a prevailing Real Value of R$11.27 per share. The current price of the firm is R$9.59. Our model computes the value of DexCom Inc from reviewing the firm fundamentals such as Shares Outstanding of 4.84 B, current valuation of 4.96 B, and Profit Margin of 24.45 % as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that DexCom's price fluctuation is not too volatile at this time. Calculation of the real value of DexCom Inc is based on 3 months time horizon. Increasing DexCom's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DexCom is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DexCom Stock. However, DexCom's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.59 | Real 11.27 | Hype 9.59 | Naive 9.3 |
The real value of DexCom Stock, also known as its intrinsic value, is the underlying worth of DexCom Inc Company, which is reflected in its stock price. It is based on DexCom's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DexCom's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of DexCom Inc helps investors to forecast how DexCom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DexCom more accurately as focusing exclusively on DexCom's fundamentals will not take into account other important factors: DexCom Total Value Analysis
DexCom Inc is currently forecasted to have takeover price of 4.96 B with market capitalization of 280.7 B, debt of 1.89 B, and cash on hands of 2.58 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DexCom fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.96 B | 280.7 B | 1.89 B | 2.58 B |
DexCom Investor Information
The book value of the company was currently reported as 19.68. The company recorded earning per share (EPS) of 28.32. DexCom Inc had not issued any dividends in recent years. DexCom Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.DexCom Asset Utilization
One of the ways to look at asset utilization of DexCom is to check how much profit was generated for every dollar of assets it reports. DexCom Inc utilizes its assets almost 5.37 percent, getting R$0.0537 for each real of assets held by the firm. A positive asset utilization denotes the company is slightly more effective with each real of assets it shows. Put another way, asset utilization of DexCom shows how effective it operates for each real spent on its assets.DexCom Profitability Analysis
The company reported the revenue of 2.17 B. Net Income was 530.6 M with profit before overhead, payroll, taxes, and interest of 1.28 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates DexCom's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in DexCom and how it compares across the competition.
About DexCom Valuation
The stock valuation mechanism determines DexCom's current worth on a weekly basis. Our valuation model uses a comparative analysis of DexCom. We calculate exposure to DexCom's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DexCom's related companies.DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 5500 people.
8 Steps to conduct DexCom's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DexCom's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DexCom's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DexCom's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DexCom's revenue streams: Identify DexCom's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DexCom's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DexCom's growth potential: Evaluate DexCom's management, business model, and growth potential.
- Determine DexCom's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DexCom's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |